Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
85 hedge funds and large institutions have $186M invested in Immunomedics Inc in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 10 closing their positions.
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
37% more capital invested
Capital invested by funds: $135M → $186M (+$50.6M)
35% more call options, than puts
Call options by funds: $6.76M | Put options by funds: $5M
5% more funds holding
Funds holding: 81 → 85 (+4)
0% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$2.33M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.86M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.2M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$818K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$491K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.99M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$246K |
| 3 |
Goldman Sachs
New York
|
-$151K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$123K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$104K |
IMMU Hedge Fund Activity: Q4 2014 in Review
85 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2014, worth a combined $186M — up 37% from $135M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new IMMU positions and 10 closed out — a net gain of 6 holders — while 22 added to existing stakes and 22 trimmed.
The largest buyer was TFS Capital, adding an estimated $2.33M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $1.99M sold.
- 85 institutional investors held Immunomedics Inc (IMMU) as of Q4 2014, up from 81 in Q3 2014.
- Funds reported $186M of Immunomedics Inc stock for Q4 2014, up 37% quarter-over-quarter.
- 16 funds opened new Immunomedics Inc positions in Q4 2014 and 10 closed out, a net change of +6 holders.
- The largest Immunomedics Inc buyer in Q4 2014 was TFS Capital, an estimated $2.33M added.
- The largest Immunomedics Inc seller in Q4 2014 was Sphera Funds Management, an estimated $1.99M sold.
Based on aggregated 13F filings for Q4 2014.